Vcreate, INC
Last verified 2026-05-08. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $1.2Mattributed |
|---|---|
| Latest round | strategic, $1.2M, 2024-01-01attributed |
| Founded | unknown |
| Headquarters | Menlo Park, USA |
| Industry | unknown |
| Stage | series-b+ |
| Website | vcreate.io |
SBIR PHASE II: HIGH THROUGHPUT AND ANTIGEN SPECIFIC T-CELL RECEPTOR DISCOVERY FOR SOLID TUMOR TREATMENTS -THE BROADER IM
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-01-01 | strategic | $1.2M | undisclosed |
Detected tech stack
Nginx 1.18.0, Ubuntu, jQuery CDN, jquery 3.6.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Strategic, $1.2M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $1.2M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | vcreate.io, read 2026-05-08 |
| Description | self-reported | vcreate.io, read 2026-05-08 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.